The study based on our follow-up cohort in real medical practice showed that overlapping SS reduced the likelihood of reaching remission or LDA by approximately 20–30% in RA patients, regardless of age, RF/ACPA status, and DAS28-CRP at first visit. This evidence concerns the gene PRTN3 and rheumatoid arthritis.